MedTrace Logo

Neurofibromatosis Type 1 Brain Tumor Genetic Risk

NCT01707836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 176

Last updated 2017-05-09

No results posted yet for this study

Summary

This study will analyze DNA samples to determine associations between maternal and offspring genetic factors and pediatric brain tumor development in children with Neurofibromatosis Type 1. Participating families (mother, father, child) will be asked to complete a short questionnaire and provide DNA samples (either saliva or blood). The information gained from your participation may one day help doctors develop strategies to reduce brain tumor risk in individuals with NF1. Please note: there is no therapy associated with this study.

Conditions

  • Neurofibromatosis Type 1
  • Pediatric Brain Tumor

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Kimberly J Johnson, PhD · Washington University School of Medicine

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2017-05-08
Completion
2017-05-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01707836 on ClinicalTrials.gov